Form 8-K - Current report:
SEC Accession No. 0001104659-23-040271
Filing Date
2023-03-31
Accepted
2023-03-31 16:56:50
Documents
14
Period of Report
2023-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2311191d1_8k.htm   iXBRL 8-K 28614
2 EXHIBIT 10.1 tm2311191d1_ex10-1.htm EX-10.1 7496
3 EXHIBIT 10.2 tm2311191d1_ex10-2.htm EX-10.2 7917
  Complete submission text file 0001104659-23-040271.txt   223590

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ispc-20230331.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ispc-20230331_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ispc-20230331_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2311191d1_8k_htm.xml XML 3638
Mailing Address 450 BEDFORD STREET SUITE 1010 LEXINGTON MA 02420
Business Address 450 BEDFORD STREET SUITE 1010 LEXINGTON MA 02420 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40501 | Film No.: 23788850
SIC: 8731 Services-Commercial Physical & Biological Research